Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

13,800

Employees13,800

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

13,800

Employees13,800

ZTS Key Statistics

Market cap

63.54B

Market cap63.54B

Price-Earnings ratio

24.69

Price-Earnings ratio24.69

Dividend yield

1.35%

Dividend yield1.35%

Average volume

3.06M

Average volume3.06M

High today

$145.22

High today$145.22

Low today

$143.26

Low today$143.26

Open price

$143.65

Open price$143.65

Volume

3.42M

Volume3.42M

52 Week high

$196.55

52 Week high$196.55

52 Week low

$139.34

52 Week low$139.34

ZTS News

Simply Wall St 18h

Zoetis’ New FDA Approval for Dectomax-CA1 Might Change the Case for Investing in ZTS

Zoetis Inc. recently received conditional approval from the U.S. FDA for Dectomax-CA1 Injectable, the first and only product permitted for prevention and treatm...

The Motley Fool 4d

My 2 Favorite Stocks to Buy Right Now

These two stocks will be at the top of my shortlist of stocks to add to in October. The S&P 500 continues to advance to new all-time highs, delivering total re...

Simply Wall St 6d

Does Zoetis Present an Opportunity After Its 22% Drop in the Past Year?

Trying to figure out your next move with Zoetis stock? You’re definitely not alone. Investors have been watching this name closely, especially as the company’s...

Analyst ratings

76%

of 21 ratings

Buy

76.2%

Hold

23.8%

Sell

More ZTS News

The Motley Fool 7d

Zoetis: A Solid Investment in the Growing Pet Medicine Market?

Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Lou Whiteman has no position in any of the stocks mentioned. Rick Munarriz has no position...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.